Published in Cancer Res on August 01, 2000
To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest (2008) 3.05
Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J (2005) 1.96
Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword. Cells (2013) 0.98
Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner. Mol Cell Biol (2005) 0.92
Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma. World J Gastroenterol (2003) 0.89
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis. J Clin Endocrinol Metab (2009) 0.88
Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours. Br J Cancer (2009) 0.87
Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am J Pathol (2002) 0.86
Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity. Endocr Relat Cancer (2014) 0.85
The role of apoptosis in autoimmune thyroid disorders and thyroid cancer. BMJ (2001) 0.83
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer. Cancer (2013) 0.78
Tunicamycin enhances TRAIL-induced apoptosis by inhibition of cyclin D1 and the subsequent downregulation of survivin. Exp Mol Med (2009) 0.77
Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer. Oncotarget (2016) 0.75
Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression. Int J Mol Med (2016) 0.75
CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 11.01
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev (2000) 8.24
A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A (1992) 4.77
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev (1999) 3.32
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int (2007) 2.75
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol (1995) 2.38
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med (1994) 2.37
CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol (1992) 2.28
Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med (1984) 2.24
Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med (1991) 2.23
Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A (1993) 2.17
The Hippocratic Oath. Lancet (1996) 2.14
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res (2001) 2.12
Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature (1989) 2.12
Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med (1997) 2.11
Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol (2007) 2.03
The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med (1989) 1.99
Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol (1993) 1.77
High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol (1998) 1.73
Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J Histochem Cytochem (1994) 1.72
Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning. EMBO J (1988) 1.60
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol (2001) 1.53
Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem (1993) 1.49
Greece is iodine sufficient. Lancet (2003) 1.48
The first recognition of the association between goiter and exophthalmos. J Endocrinol Invest (1983) 1.47
CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem (1993) 1.46
Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol (1998) 1.43
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol (1995) 1.43
Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol (1991) 1.42
Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci (2001) 1.36
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med (1992) 1.36
Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer (1998) 1.35
Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol (1996) 1.31
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid (1997) 1.28
Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med (1996) 1.27
Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands. J Biol Chem (1994) 1.24
Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med (1994) 1.23
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Cancer Res (2001) 1.20
The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function. J Biol Chem (1996) 1.20
Association of Thyrotoxicosis and Auto-immune Thyroiditis. Br Med J (1961) 1.20
In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci (2001) 1.19
Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion. J Clin Endocrinol Metab (1999) 1.17
Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol (2001) 1.16
The single thyroid nodule. Br J Surg (1972) 1.16
Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur J Immunol (1990) 1.16
Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab (1983) 1.15
Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest (1994) 1.15
Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene (2006) 1.15
Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid (1997) 1.14
Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci (1995) 1.13
Neural and muscular manifestations of hypothyroidism. Arch Neurol (1973) 1.12
Distribution of intermediate filament proteins in normal and diseased human glomeruli. Am J Pathol (1986) 1.11
Carbohydrate-protein interactions in vascular biology. Annu Rev Cell Dev Biol (1995) 1.10
CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling. Proc Natl Acad Sci U S A (1992) 1.10
Regulation of CD45 engagement by the B-cell receptor CD22. Proc Natl Acad Sci U S A (1995) 1.10
A gene expression signature that distinguishes desmoid tumours from nodular fasciitis. J Pathol (2006) 1.10
The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma. Oncogene (2001) 1.09
Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol (2000) 1.09
VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation. FASEB J (2007) 1.05
Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol (1993) 1.04
Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med (1996) 1.02
Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid (2000) 1.00
Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion. J Biol Chem (1994) 1.00
Localization of hyaluronan in mouse embryos during implantation, gastrulation and organogenesis. Differentiation (1993) 0.99
Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol (2003) 0.98
Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis. Kidney Int (1995) 0.98
Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J (1996) 0.98
The serumtyrosine level as an index of thyroid function. J Endocrinol (1966) 0.97
CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene (1995) 0.97
Influence of iodine intake after treatment with antithyroid drugs. Lancet (1965) 0.95
The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med (1990) 0.92
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certification. Ann Biol Clin (Paris) (1996) 0.92
Congenital goiter with impaired thyroglobulin synthesis. J Clin Endocrinol Metab (1973) 0.92
Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion. Blood (1999) 0.91
Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease. J Exp Med (1996) 0.91
Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem (1996) 0.91
Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism? J Endocrinol Invest (1991) 0.90
Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression. Cancer Res (1998) 0.90
Endemic goiter in Greece: metabolic studies. J Clin Endocrinol Metab (1966) 0.90
Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab (1966) 0.89
Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur J Immunol (1994) 0.89
Antioxidant agents in the treatment of Graves' ophthalmopathy. Am J Ophthalmol (2000) 0.89
Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase. Am J Pathol (1998) 0.89
Endemic goiter in Greece: epidemiologic and genetic studies. J Clin Endocrinol Metab (1966) 0.88
Dopamine-induced lymphoma cell death by inhibition of hormone release. Scand J Immunol (1992) 0.88
Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol Metab (2001) 0.88
125I-sodium iothalamate in the determination of the glomerular filtration rate. Nucl Med (Stuttg) (1967) 0.87
Hypothyroidism and glaucoma. A study of 100 hypothyroid patients. Am J Ophthalmol (2001) 0.87
Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer (1992) 0.87
Location of gp330/alpha 2-m receptor-associated protein (alpha 2-MRAP) and its binding sites in kidney: distribution of endogenous alpha 2-MRAP is modified by tissue processing. Eur J Cell Biol (1993) 0.87
Comparison of the early thyroidal iodide clearance with estimates obtained at later intervals. J Endocrinol (1966) 0.87
CD22 binds to alpha-2,6-sialyltransferase-dependent epitopes on COS cells. Cell (1992) 0.86